Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
REGENXBIO Inc. (RGNX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/06/2023 |
4
| Fox Allan M. (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/06/2023 |
4
| Tasse Daniel (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/06/2023 |
4
| STUMP DAVID C (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/06/2023 |
4
| MIGAUSKY GEORGE V (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/06/2023 |
4
| Glucksmann Alexandra (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/06/2023 |
4
| KARABELAS ARGERIS N (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/06/2023 |
4
| Bennett Jean (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 06/06/2023 |
4
| Zachary Jennifer (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,486 shares
@ $0
Granted 17,892 options to buy
@ $19.72, valued at
$352.8k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| PAKOLA STEVE (Chief Medical Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Paid exercise price by delivering 1,837 shares
@ $22.68, valued at
$41.7k
Sold 3,138 shares
@ $22.1668, valued at
$69.6k
Granted 90,588 shares
@ $0
Granted 44,155 options to buy
@ $22.25, valued at
$982.4k
|
|
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/31/2022 |
4
| Vasista Vittal (CFO) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 2,400 shares
@ $30.2386, valued at
$72.6k
|
|
| 08/08/2022 |
4
| Vasista Vittal (CFO) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 400 shares
@ $35, valued at
$14k
Sold 17,280 shares
@ $35.1872, valued at
$608k
|
|
| 08/03/2022 |
4
| Vasista Vittal (CFO) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 2,400 shares
@ $31.255, valued at
$75k
|
|
| 07/15/2022 |
4
| Vasista Vittal (CFO) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 4,332 shares
@ $30.0065, valued at
$130k
Sold 468 shares
@ $30, valued at
$14k
|
|
| 06/07/2022 |
4
| Zachary Jennifer (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 6,020 shares
@ $0
Granted 29,739 options to buy
@ $22.84, valued at
$679.2k
|
|
| 06/07/2022 |
4
| Tasse Daniel (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,010 shares
@ $0
Granted 15,324 options to buy
@ $22.84, valued at
$350k
|
|
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/07/2022 |
4
| Glucksmann Alexandra (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,010 shares
@ $0
Granted 15,324 options to buy
@ $22.84, valued at
$350k
|
|
| 06/07/2022 |
4
| Fox Allan M. (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,010 shares
@ $0
Granted 15,324 options to buy
@ $22.84, valued at
$350k
|
|
| 06/07/2022 |
4
| Bennett Jean (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 3,010 shares
@ $0
Granted 15,324 options to buy
@ $22.84, valued at
$350k
|
|
| 01/24/2022 |
4
| Vasista Vittal (CFO) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Exercised 29,900 options to buy
@ $0.85, valued at
$25.4k
|
|
| 01/04/2022 |
4
| Vasista Vittal (CFO) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 8,900 shares
@ $0
Granted 42,500 options to buy
@ $34.31, valued at
$1.5M
|
|
| 01/04/2022 |
4
| Simpson Curran (Chief Oper. & Tech. Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Paid exercise price by delivering 1,332 shares
@ $32.7, valued at
$43.6k
Granted 10,700 shares
@ $0
Granted 51,100 options to buy
@ $34.31, valued at
$1.8M
|
|
| 01/04/2022 |
4
| PAKOLA STEVE (Chief Medical Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Paid exercise price by delivering 1,152 shares
@ $32.7, valued at
$37.7k
Sold 1,598 shares
@ $33.75, valued at
$53.9k
Granted 8,900 shares
@ $0
Granted 42,500 options to buy
@ $34.31, valued at
$1.5M
|
|
| 01/04/2022 |
4
| Danos Olivier (Chief Scientific Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Granted 555 shares
@ $33.0225, valued at
$18.3k
Granted 1 shares
@ $27.795, valued at
$27.8
Paid exercise price by delivering 1,221 shares
@ $32.7, valued at
$39.9k
Granted 10,700 shares
@ $0
Granted 51,100 options to buy
@ $34.31, valued at
$1.8M
|
|
| 01/04/2022 |
4
| Christmas Patrick J. (Chief Legal Officer) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Paid exercise price by delivering 1,332 shares
@ $32.7, valued at
$43.6k
Granted 7,900 shares
@ $0
Granted 37,400 options to buy
@ $34.31, valued at
$1.3M
|
|
| 01/04/2022 |
4
| Mills Kenneth T. (President and CEO) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Paid exercise price by delivering 3,636 shares
@ $32.7, valued at
$118.9k
Granted 35,796 shares
@ $0
Granted 170,188 options to buy
@ $34.31, valued at
$5.8M
|
|
| 12/27/2021 |
4
| Fox Allan M. (Director) has filed a Form 4 on REGENXBIO Inc.|
Txns:
| Sold 61,638 shares
@ $34.4037, valued at
$2.1M
Sold 44,908 shares
@ $34.9185, valued at
$1.6M
Sold 6,323 shares
@ $35.8475, valued at
$226.7k
|
|
|
|
|